More than a few readers likely saw that Immunomedics(IMMU) was bought this week for $21 billion. If you look at the history you see that they had the same Chairman of the Board for its entire existence of 38 years. The share price was up and down like crazy similar to what RVX has experienced over that time as well. Early in its existence the share price was up to around $45 and then years later down to around $ .50 and everywhere In between both before and after, until this week when Gilead said they would buy them for $21 billion. They went through many of the same challenges we have experienced over the years and still survived to eventually be acquired for a great price.

This part is just for KK2 - There appears to be a licensing agreement in place for China, Japan and some other Asian countries and yet a $21 billion sale price was still arrived at.

There is hope for RVX yet SF. Maybe backing off on the Negative Nancy path would be a better place to be for a while. Sometimes it's better to make the words you speak sweat in case you have to eat them.

tada